Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 11791 | 4.705 |
09:34 ET | 744 | 4.6573 |
09:36 ET | 2653 | 4.57 |
09:38 ET | 200 | 4.585 |
09:39 ET | 15523 | 4.5 |
09:41 ET | 1300 | 4.56 |
09:43 ET | 200 | 4.56 |
09:45 ET | 5552 | 4.5 |
09:48 ET | 1818 | 4.515 |
09:50 ET | 300 | 4.53 |
09:52 ET | 282 | 4.55 |
09:54 ET | 1200 | 4.55 |
09:56 ET | 1014 | 4.53 |
09:57 ET | 1850 | 4.5 |
09:59 ET | 1214 | 4.49 |
10:01 ET | 2891 | 4.475 |
10:03 ET | 12057 | 4.52 |
10:06 ET | 708 | 4.5 |
10:08 ET | 1985 | 4.505 |
10:10 ET | 1280 | 4.5 |
10:12 ET | 300 | 4.49 |
10:14 ET | 200 | 4.5 |
10:15 ET | 709 | 4.49 |
10:17 ET | 700 | 4.5 |
10:19 ET | 300 | 4.5 |
10:21 ET | 1550 | 4.5 |
10:24 ET | 845 | 4.54 |
10:26 ET | 2428 | 4.505 |
10:28 ET | 1997 | 4.52 |
10:30 ET | 1470 | 4.5 |
10:32 ET | 1200 | 4.5 |
10:33 ET | 200 | 4.53 |
10:35 ET | 3080 | 4.52 |
10:37 ET | 1626 | 4.5 |
10:39 ET | 810 | 4.5 |
10:42 ET | 3841 | 4.53 |
10:44 ET | 1064 | 4.51 |
10:46 ET | 1080 | 4.5 |
10:48 ET | 427 | 4.5 |
10:50 ET | 605 | 4.5 |
10:51 ET | 1506 | 4.49 |
10:53 ET | 200 | 4.49 |
10:55 ET | 445 | 4.5 |
10:57 ET | 138 | 4.495 |
11:00 ET | 302 | 4.495 |
11:02 ET | 521 | 4.495 |
11:04 ET | 2477 | 4.49 |
11:06 ET | 312 | 4.49 |
11:08 ET | 201 | 4.49 |
11:09 ET | 1100 | 4.48 |
11:11 ET | 2279 | 4.465 |
11:13 ET | 500 | 4.47 |
11:15 ET | 1649 | 4.44 |
11:20 ET | 1889 | 4.43 |
11:22 ET | 931 | 4.42 |
11:24 ET | 200 | 4.42 |
11:26 ET | 300 | 4.42 |
11:29 ET | 425 | 4.42 |
11:31 ET | 2446 | 4.43 |
11:36 ET | 1143 | 4.425 |
11:38 ET | 2175 | 4.4 |
11:40 ET | 335 | 4.41 |
11:42 ET | 1200 | 4.41 |
11:44 ET | 3226 | 4.45 |
11:45 ET | 1392 | 4.43 |
11:47 ET | 302 | 4.43 |
11:49 ET | 1000 | 4.415 |
11:51 ET | 3145 | 4.41 |
11:54 ET | 300 | 4.41 |
11:56 ET | 1720 | 4.405 |
11:58 ET | 100 | 4.41 |
12:00 ET | 2145 | 4.4 |
12:02 ET | 2400 | 4.4 |
12:03 ET | 400 | 4.38 |
12:05 ET | 3099 | 4.38 |
12:09 ET | 7766 | 4.42 |
12:12 ET | 425 | 4.42 |
12:14 ET | 2470 | 4.405 |
12:16 ET | 300 | 4.405 |
12:20 ET | 3692 | 4.4 |
12:21 ET | 191 | 4.4 |
12:23 ET | 344 | 4.4 |
12:25 ET | 1500 | 4.4 |
12:27 ET | 7823 | 4.35 |
12:30 ET | 13491 | 4.37 |
12:32 ET | 363 | 4.38 |
12:34 ET | 5997 | 4.355 |
12:36 ET | 700 | 4.36 |
12:38 ET | 500 | 4.37 |
12:39 ET | 300 | 4.365 |
12:41 ET | 4332 | 4.38 |
12:43 ET | 100 | 4.3867 |
12:48 ET | 1876 | 4.39 |
12:50 ET | 1521 | 4.39 |
12:52 ET | 20083 | 4.405 |
12:54 ET | 1300 | 4.4099 |
12:56 ET | 2700 | 4.39 |
12:57 ET | 3227 | 4.3999 |
12:59 ET | 402 | 4.395 |
01:01 ET | 6554 | 4.39 |
01:03 ET | 1198 | 4.3801 |
01:06 ET | 2996 | 4.4 |
01:08 ET | 3127 | 4.41 |
01:12 ET | 900 | 4.41 |
01:14 ET | 1568 | 4.41 |
01:15 ET | 647 | 4.405 |
01:17 ET | 2062 | 4.405 |
01:19 ET | 6043 | 4.395 |
01:21 ET | 400 | 4.395 |
01:24 ET | 600 | 4.4 |
01:26 ET | 2652 | 4.42 |
01:28 ET | 1154 | 4.425 |
01:30 ET | 6728 | 4.41 |
01:32 ET | 1100 | 4.42 |
01:33 ET | 2276 | 4.425 |
01:35 ET | 4660 | 4.445 |
01:37 ET | 657 | 4.45 |
01:39 ET | 1500 | 4.457 |
01:42 ET | 93553 | 4.4 |
01:44 ET | 2400 | 4.405 |
01:46 ET | 4505 | 4.405 |
01:48 ET | 2531 | 4.4 |
01:50 ET | 11614 | 4.39 |
01:51 ET | 6937 | 4.395 |
01:53 ET | 1831 | 4.4 |
01:55 ET | 1242 | 4.395 |
01:57 ET | 4000 | 4.4 |
02:00 ET | 521 | 4.4 |
02:02 ET | 456 | 4.41 |
02:04 ET | 3562 | 4.3703 |
02:06 ET | 1100 | 4.379 |
02:08 ET | 200 | 4.38 |
02:09 ET | 100 | 4.38 |
02:13 ET | 245 | 4.375 |
02:15 ET | 100 | 4.375 |
02:20 ET | 400 | 4.39 |
02:22 ET | 300 | 4.4 |
02:24 ET | 746 | 4.395 |
02:26 ET | 400 | 4.395 |
02:27 ET | 7049 | 4.39 |
02:29 ET | 1262 | 4.395 |
02:31 ET | 2832 | 4.4 |
02:33 ET | 1200 | 4.39 |
02:36 ET | 100 | 4.395 |
02:38 ET | 354 | 4.395 |
02:40 ET | 400 | 4.39 |
02:42 ET | 306 | 4.395 |
02:44 ET | 7836 | 4.4 |
02:45 ET | 400 | 4.4 |
02:47 ET | 1270 | 4.395 |
02:49 ET | 655 | 4.4 |
02:51 ET | 400 | 4.395 |
02:54 ET | 600 | 4.395 |
02:56 ET | 11773 | 4.4 |
02:58 ET | 5489 | 4.385 |
03:00 ET | 1858 | 4.38 |
03:02 ET | 3604 | 4.38 |
03:03 ET | 200 | 4.4 |
03:05 ET | 250 | 4.3836 |
03:07 ET | 300 | 4.4 |
03:09 ET | 200 | 4.395 |
03:12 ET | 644 | 4.4 |
03:14 ET | 800 | 4.4 |
03:16 ET | 3955 | 4.385 |
03:18 ET | 200 | 4.385 |
03:20 ET | 500 | 4.385 |
03:21 ET | 2597 | 4.385 |
03:23 ET | 217 | 4.385 |
03:25 ET | 2163 | 4.39 |
03:27 ET | 564 | 4.385 |
03:30 ET | 9073 | 4.385 |
03:32 ET | 2680 | 4.39 |
03:34 ET | 2717 | 4.395 |
03:36 ET | 200 | 4.395 |
03:38 ET | 5934 | 4.4 |
03:39 ET | 1076 | 4.4 |
03:41 ET | 2196 | 4.395 |
03:43 ET | 300 | 4.395 |
03:45 ET | 600 | 4.395 |
03:48 ET | 18213 | 4.4 |
03:50 ET | 3099 | 4.4 |
03:52 ET | 4792 | 4.4 |
03:54 ET | 2254 | 4.4 |
03:56 ET | 4181 | 4.395 |
03:57 ET | 9448 | 4.4 |
03:59 ET | 60939 | 4.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 501.5M | -3.1x | --- |
Verve Therapeutics Inc | 504.4M | -2.1x | --- |
Adlai Nortye Ltd | 481.5M | -1.8x | --- |
Shattuck Labs Inc | 495.5M | -5.4x | --- |
Altimmune Inc | 511.9M | -4.5x | --- |
Kalvista Pharmaceuticals Inc | 509.6M | -3.8x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $501.5M |
---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 114.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.90 |
EPS | $-1.42 |
Book Value | $-0.20 |
P/E Ratio | -3.1x |
Price/Sales (TTM) | 50.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -645.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.